• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma.

作者信息

Weng Wen-Kai, Iragavarapu Chaitanya, Weng Gavin M, Hoppe Richard T, Hiniker Susan, Khodadoust Michael S, Kim Youn H

机构信息

Blood and Marrow Transplantation & Cellular Therapy Division, Department of Medicine, Stanford University School of Medicine, Stanford, CA.

Department of Dermatology, Stanford University School of Medicine, Stanford, CA.

出版信息

Blood Neoplasia. 2024 Mar 29;1(2):100007. doi: 10.1016/j.bneo.2024.100007. eCollection 2024 Jun.

DOI:10.1016/j.bneo.2024.100007
PMID:40454397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082105/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0e/12082105/3c6948d9a84e/BNEO_NEO-2024-000196-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0e/12082105/c158407f1b8d/BNEO_NEO-2024-000196-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0e/12082105/3c6948d9a84e/BNEO_NEO-2024-000196-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0e/12082105/c158407f1b8d/BNEO_NEO-2024-000196-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0e/12082105/3c6948d9a84e/BNEO_NEO-2024-000196-gr1.jpg

相似文献

1
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma.难治性/复发性皮肤细胞毒性T细胞淋巴瘤患者接受异基因移植后的长期缓解
Blood Neoplasia. 2024 Mar 29;1(2):100007. doi: 10.1016/j.bneo.2024.100007. eCollection 2024 Jun.
2
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study.复发/难治性B细胞非霍奇金淋巴瘤异基因造血干细胞移植后的长期结局：一项意大利多中心协作研究
Transplant Cell Ther. 2025 Jun 18. doi: 10.1016/j.jtct.2025.06.004.
3
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.序贯 CD7 CAR T 细胞治疗与异基因造血干细胞移植而不进行移植物抗宿主病预防。
N Engl J Med. 2024 Apr 25;390(16):1467-1480. doi: 10.1056/NEJMoa2313812.
4
Transplantation.移植
Cancer Treat Res. 2019;176:269-287. doi: 10.1007/978-3-319-99716-2_13.
5
Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant.分析在移植后复发的复发/难治性 B 细胞急性淋巴细胞白血病患者中，在接受 CAR-T 细胞治疗后进行第二次同种异体 HSCT 的获益。
Front Immunol. 2023 Jul 4;14:1191382. doi: 10.3389/fimmu.2023.1191382. eCollection 2023.
6
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.复发或难治性淋巴瘤患者的异基因造血干细胞移植：大剂量传统预处理与氟达拉滨减低强度预处理方案的比较
Ann Oncol. 2002 Jan;13(1):135-9. doi: 10.1093/annonc/mdf010.
7
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.T 细胞耗竭的异基因移植而不进行供者白细胞输注可使多次复发的淋巴瘤患者获得极好的长期生存。移植后复发的生存预测因素。
Leuk Lymphoma. 2011 Feb;52(2):214-22. doi: 10.3109/10428194.2010.538777. Epub 2010 Dec 10.
8
Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma.评估莫加莫拉单抗治疗原发性皮肤T细胞淋巴瘤的疗效。
Immunotherapy. 2025 Jun;17(8):551-559. doi: 10.1080/1750743X.2025.2520153. Epub 2025 Jun 24.
9
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.异基因造血干细胞移植后复发性皮肤T细胞淋巴瘤的管理：附代表性患者病例回顾
Dermatol Ther. 2022 Jul;35(7):e15538. doi: 10.1111/dth.15538. Epub 2022 May 9.
10
A systematic overview of chemotherapy effects in acute myeloid leukaemia.急性髓系白血病化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321.

引用本文的文献

1
CHOP is insufficient for newly-diagnosed subcutaneous panniculitis-like T-cell lymphoma patients: a retrospective study of 32 patients in China.CHOP方案对新诊断的皮下脂膜炎样T细胞淋巴瘤患者疗效不足：中国32例患者的回顾性研究
BMC Cancer. 2025 Jul 24;25(1):1204. doi: 10.1186/s12885-025-14634-7.

本文引用的文献

1
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders.皮下脂膜炎样 T 细胞淋巴瘤和相关亲脂性淋巴增生性疾病患者的临床和病理特征及结局。
JAMA Dermatol. 2022 Oct 1;158(10):1167-1174. doi: 10.1001/jamadermatol.2022.3347.
2
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation.干细胞移植前原发性皮肤γδ淋巴瘤的放射治疗
Cancer Invest. 2023 Jan 31:1-8. doi: 10.1080/07357907.2021.1919696.
3
Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.
非清髓性异基因移植可实现皮肤 T 细胞淋巴瘤的临床和分子缓解。
Blood Adv. 2020 Sep 22;4(18):4474-4482. doi: 10.1182/bloodadvances.2020001627.
4
Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas.难治性蕈样肉芽肿和原发性皮肤γδT细胞淋巴瘤异基因干细胞移植的疗效
Leuk Lymphoma. 2020 Dec;61(12):2955-2961. doi: 10.1080/10428194.2020.1790555. Epub 2020 Jul 9.
5
Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs.容积调强弧形放疗与三维打印组织等效填充物治疗双侧腿部难治性原发性皮肤γδ淋巴瘤
Pract Radiat Oncol. 2019 Jul-Aug;9(4):220-225. doi: 10.1016/j.prro.2019.02.016. Epub 2019 Mar 2.
6
Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population.皮下脂膜炎样T细胞淋巴瘤的造血干细胞移植：亚洲人群单中心经验
Int J Hematol. 2019 Feb;109(2):187-196. doi: 10.1007/s12185-018-02568-9. Epub 2018 Dec 13.
7
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.原发性皮肤侵袭性亲表皮细胞毒性T细胞淋巴瘤：对2016年世界卫生组织皮肤淋巴瘤分类中一个临时实体的重新评估。
Mod Pathol. 2017 May;30(5):761-772. doi: 10.1038/modpathol.2016.240. Epub 2017 Jan 27.
8
Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.皮下脂膜炎样T细胞淋巴瘤和未另行指定的外周T细胞淋巴瘤的生存情况：监测、流行病学和最终结果数据库的倾向匹配分析
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):373-8. doi: 10.1016/j.clml.2016.04.015. Epub 2016 May 4.
9
Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.原发性皮肤 γδ T 细胞淋巴瘤和难治性皮下脂膜炎样 T 细胞淋巴瘤的造血干细胞移植。
J Am Acad Dermatol. 2015 Jun;72(6):1010-5.e5. doi: 10.1016/j.jaad.2015.01.003.
10
Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome.儿童皮下脂膜炎样T细胞淋巴瘤：11例多灶性病例的详细临床病理描述及高频率噬血细胞综合征
Br J Dermatol. 2015 Mar;172(3):793-7. doi: 10.1111/bjd.13440. Epub 2015 Feb 5.